Oncocyte Corporation - Common Shares, No Par Value (OCX)

53 filings reported holding OCX - Oncocyte Corporation - Common Shares, No Par Value as of Q1 2020.
Oncocyte Corporation - Common Shares, No Par Value (OCX) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26.1M shares of 28.5M outstanding shares and own 91.73% of the company stock.
Largest 10 shareholders include BROADWOOD CAPITAL INC (13.7M shares), PURA VIDA INVESTMENTS, LLC (5.58M shares), EMERALD MUTUAL FUND ADVISERS TRUST (2.04M shares), BlackRock Inc. (1.57M shares), STATE STREET CORP (429K shares), P.A.W. CAPITAL CORP (350K shares), GEODE CAPITAL MANAGEMENT, LLC (327K shares), NORTHERN TRUST CORP (295K shares), Phoenix Holdings Ltd. (264K shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (230K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.